-
Exciting Research Finding Ushers in New Era in Breast Cancer Treatment
Definitive results from a large international breast cancer study that included Georgetown Lombardi Comprehensive Cancer Center show that a genetic test can help determine the course of a woman’s treatment and will ultimately spare many women with the most common subtype of breast cancer from receiving chemotherapy.
Category: Lombardi Stories
-
Inspiration and Celebration at the 13th-Annual Women & Wine
The 13th-annual Women & Wine event, which took place on April 18, raised over 30,000 for the Nina Hyde Center for Breast Cancer Research at Georgetown Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories
-
Research in a Minute: Giuseppe Giaccone, MD, PhD
As associate director of clinical research at Georgetown Lombardi Comprehensive Cancer Center and professor of medical oncology and pharmacology at Georgetown University School of Medicine, Giuseppe Giaccone, MD, PhD, leads a team of researchers in studying thymic carcinoma, also known as cancer of the thymus.
Category: Lombardi Stories
-
Frederick National Laboratory and Georgetown Launch Research and Education Collaboration
A new collaboration between Georgetown University and the Frederick National Laboratory for Cancer Research in Frederick, Maryland, aims to expand both institutions’ research and training missions in the biomedical sciences.
Category: Lombardi Stories
-
Breast Cancer
Uncategorized
-
Family History Increases Breast Cancer Risk Even in Older Women: Weighing Screening Options
Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
A study led by Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center, that combined an agent that blocks blood vessel formation with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer who had not been previously treated.
Category: News Release
-
Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
Category: News Release
-
Sharing Innovation and Motivation at the Ruesch Center Symposium
Nearly 300 medical professionals, patients, caregivers and advocates attended the 8th Annual Ruesch Center Symposium on December 1, listening to lectures on topics including precision medicine, immunotherapy, proton therapy and molecular imaging.
Category: Lombardi Stories
-
Some Cancer Therapies May Provide a New Way to Treat High Blood Pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer an advance in hypertension treatment.
Category: Lombardi Stories
